Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ACRX

AcelRx

$2.15

-3.2 (-59.81%)

06:15
10/13/17
10/13
06:15
10/13/17
06:15
Downgrade
AcelRx rating change at Jefferies »

AcelRx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ACRX

AcelRx

$5.35

-0.15 (-2.73%)

14:08
10/12/17
10/12
14:08
10/12/17
14:08
Recommendations
AcelRx analyst commentary at Roth Capital »

AcelRx's Dsuvia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 12

    Oct

  • 06

    Nov

JPM

JPMorgan

, C

Citi

09:10
10/12/17
10/12
09:10
10/12/17
09:10
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS:…

JPM

JPMorgan

C

Citi

AVXL

Anavex

$4.02

-0.13 (-3.13%)

ARDX

Ardelyx

INFI

Infinity Pharmaceuticals

$1.67

0.21 (14.38%)

ACRX

AcelRx

$5.35

-0.15 (-2.73%)

DPZ

Domino's Pizza

HA

Hawaiian Holdings

$40.00

-0.5 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 03

    Nov

  • 05

    Nov

  • 06

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

ACRX

AcelRx

$5.35

-0.15 (-2.73%)

08:49
10/12/17
10/12
08:49
10/12/17
08:49
Conference/Events
AcelRx to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 06

    Nov

ACRX

AcelRx

$5.35

-0.15 (-2.73%)

07:12
10/12/17
10/12
07:12
10/12/17
07:12
Conference/Events
Breaking Conference/Events news story on AcelRx »

FDA PDUFA Date for AcelRx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 06

    Nov

ACRX

AcelRx

$5.35

-0.15 (-2.73%)

06:49
10/12/17
10/12
06:49
10/12/17
06:49
Hot Stocks
Breaking Hot Stocks news story on AcelRx »

AcelRx down 62.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 06

    Nov

ACRX

AcelRx

$5.35

-0.15 (-2.73%)

06:49
10/12/17
10/12
06:49
10/12/17
06:49
Hot Stocks
AcelRx receives CRL from FDA for DSUVIA »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 06

    Nov

Over a month ago
ACRX

AcelRx

$3.15

-0.1 (-3.08%)

04:55
09/14/17
09/14
04:55
09/14/17
04:55
Conference/Events
AcelRx management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 25

    Sep

  • 26

    Sep

  • 12

    Oct

ACRX

AcelRx

$3.25

0.05 (1.56%)

09:59
09/13/17
09/13
09:59
09/13/17
09:59
Conference/Events
AcelRx management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 25

    Sep

  • 26

    Sep

  • 12

    Oct

ACRX

AcelRx

$2.90

-0.05 (-1.69%)

05:56
08/09/17
08/09
05:56
08/09/17
05:56
Upgrade
AcelRx rating change at Stifel »

AcelRx upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.